| 7.19 0.3 (4.35%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.11 |
1-year : | 10.64 |
| Resists | First : | 7.8 |
Second : | 9.11 |
| Pivot price | 6.97 |
|||
| Supports | First : | 6.81 |
Second : | 6.19 |
| MAs | MA(5) : | 7.16 | MA(20) : | 6.86  |
| MA(100) : | 6.17 |
MA(250) : | 0 | |
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 52.5 |
D(3) : | 59.1 |
| RSI | RSI(14): 54 |
|||
| 52-week | High : | 15.36 | Low : | 3.43 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CV ] has closed below upper band by 31.0%. Bollinger Bands are 43.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 40 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 7.41 - 7.45 | 7.45 - 7.49 |
| Low: | 6.79 - 6.85 | 6.85 - 6.89 |
| Close: | 7.11 - 7.19 | 7.19 - 7.26 |
CapsoVision, Inc. operates as a medical technology firm, specializing in creating innovative solutions for diagnosing conditions within the gastrointestinal tract. Their offerings encompass cutting-edge capsule endoscopy systems, specifically CapsoCam Plus and CapsoCam Colon, alongside advanced artificial intelligence-driven imaging platforms.
Sat, 13 Jun 2026
CV | CapsoVision, Inc. Common Stock Insider Trading - Quiver Quantitative
Fri, 12 Jun 2026
CapsoVision shareholders re-elect directors and approve auditor at annual meeting - Investing.com
Wed, 03 Jun 2026
CV News | CAPSOVISION INC (NASDAQ:CV) - ChartMill
Wed, 03 Jun 2026
CapsoVision (CV) finance chief awarded 92,212 stock options at $6.90 strike - Stock Titan
Thu, 14 May 2026
CapsoVision, Inc 1Q 2026: Revenue $2.79M, EPS $(0.15) — 10-Q Summary - TradingView
Thu, 26 Mar 2026
161,000 patients used CapsoVision's camera pill as sales climbed - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 50 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 32 (%) |
| Held by Institutions | 8.1 (%) |
| Shares Short | 1,410 (K) |
| Shares Short P.Month | 1,350 (K) |
| EPS | -1.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.28 |
| Profit Margin | -198.9 % |
| Operating Margin | -254.1 % |
| Return on Assets (ttm) | -88.2 % |
| Return on Equity (ttm) | -185.1 % |
| Qtrly Rev. Growth | 0.3 % |
| Gross Profit (p.s.) | 0.14 |
| Sales Per Share | 0.27 |
| EBITDA (p.s.) | -0.54 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -24 (M) |
| Levered Free Cash Flow | -13 (M) |
| PE Ratio | -6.79 |
| PEG Ratio | 0 |
| Price to Book value | 25.67 |
| Price to Sales | 26.49 |
| Price to Cash Flow | -15.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|